关于《脂质体两性霉素B对HIV感染患者内脏利什曼病二级预防的疗效》的评论 - Suppr | 超能文献

Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.

作者信息

Collazos Julio

出版信息

J Antimicrob Chemother. 2008 Feb;61(2):466-7; author reply 467. doi: 10.1093/jac/dkm478. Epub 2007 Dec 11.

DOI:10.1093/jac/dkm478

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.关于《脂质体两性霉素B对HIV感染患者内脏利什曼病二级预防的疗效》的评论

J Antimicrob Chemother. 2008 Feb;61(2):466-7; author reply 467. doi: 10.1093/jac/dkm478. Epub 2007 Dec 11.

2

Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.尽管免疫缺陷程度可忽略不计，但在人类免疫缺陷病毒（HIV）感染期间仍发生了内脏利什曼病的弥漫性皮肤播散：脂质体两性霉素B给药多次失败，随后成功长期给予喷他脒和巴龙霉素。

Int J Antimicrob Agents. 2008 Jun;31(6):590-2. doi: 10.1016/j.ijantimicag.2008.02.007. Epub 2008 May 5.

3

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.脂质体两性霉素 B 治疗人免疫缺陷病毒合并内脏利什曼病患者：印度比哈尔邦的 2 年治疗结局。

Clin Infect Dis. 2011 Oct;53(7):e91-8. doi: 10.1093/cid/cir521.

4

Liposomal amphotericin B for the treatment of visceral leishmaniasis.脂质体两性霉素B用于治疗内脏利什曼病。

Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28.

5

Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.脂质体两性霉素B用于HIV感染患者内脏利什曼病二级预防的疗效。

J Antimicrob Chemother. 2007 Oct;60(4):837-42. doi: 10.1093/jac/dkm294. Epub 2007 Aug 7.

6

Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV.脂质体两性霉素B作为一名感染HIV患者内脏利什曼病的一线及二线预防性治疗药物。

Ann Ital Med Int. 2000 Apr-Jun;15(2):169-71.

7

[First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].[法国南部儿童内脏利什曼病的一线脂质体两性霉素B治疗]

Arch Pediatr. 2005 Jul;12(7):1102-8. doi: 10.1016/j.arcped.2005.01.009.

8

Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.一名HIV阳性患者中对脂质体两性霉素B耐药的内脏利什曼病的皮肤表现

Arch Dermatol. 2006 Jun;142(6):787-9. doi: 10.1001/archderm.142.6.787.

9

Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases.脂质体两性霉素B治疗和二级预防HIV感染患者内脏利什曼病的疗效：两例报告

J Antimicrob Chemother. 1993 Oct;32(4):657-9. doi: 10.1093/jac/32.4.657.

10

Successful treatment of visceral leishmaniasis with liposomal amphotericin B.脂质体两性霉素B成功治疗内脏利什曼病。

Acta Biomed. 2006;77 Suppl 2:22-5.